載入...
Treatment of metastatic colorectal cancer: focus on panitumumab
Targeted agents are an important therapeutic option in the treatment of metastatic colorectal cancer (mCRC). Panitumumab is a recombinant, fully humanized, immunoglobulin G2 monoclonal antibody that targets the epidermal growth factor receptor (EGFR) with efficacy in mCRC as monotherapy and in combi...
Na minha lista:
| 發表在: | Cancer Manag Res |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4484697/ https://ncbi.nlm.nih.gov/pubmed/26150735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S71821 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|